Autoimmune DiseasesVolume 2012 (2012), Article ID 734069, 1 pagedoi:10.1155/2012/734069

Erratum

Erratum to: A Systematic Review of Serum Biomarkers Anti-Cyclic Citrullinated Peptide and Rheumatoid Factor as Tests for Rheumatoid Arthritis

Peter C. Taylor,¹ Juliane Gartemann,² Jeanie Hsieh,² and James Creeden²

¹Kennedy Institute of Rheumatology, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford Botnar Research Centre, Windmill Road Headington, Oxford OX3 7LD, UK²Roche Diagnostics, Ltd., Forrenstraße, 6343 Rotkreuz, Switzerland

Received 6 November 2011; Accepted 20 November 2011

Copyright © 2012 Peter C. Taylor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Table 3: 2010 ACR/EULAR scoring criteria for RA. The following table provides the scoring criteria for different domains of evaluation. For each cell in the table for which the patient satisfies the condition, the cell is scored by the number of points at the top of the column in which it is found. The patient’s score is the sum of the scores for the individual cells. Patients with a total score of 6 or more points are diagnosed as having RA.

Number of points
0
1
2
3
5

Joint involvement
1 medium-large joint
2–10 medium-large joints
1–3 small joints
4–10 small joints
>10 small joints

Serology
Negative for both RF and anti-CCP

Positive for either RF or anti-CCP at low titer (between 1x–3x upper limit of normal)
Positive for either RF or anti-CCP at high titer (>3x upper limit of normal)

Duration of synovitis
<6 weeks
≥6 weeks

Acute phase reactants
Normal CRP and ESR
Abnormal CRP or ESR

Source: